Ranok Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $5M

  • Investors
  • 6

Ranok Therapeutics General Information

Description

Developer of clinical-stage biopharmaceuticals designed for the discovery and development of novel therapeutics. The company's technology utilises a proprietary chaperone-mediated protein degradation platform and a chaperone-tether library to regulate protein folding and stability, providing oncology patients with targeted therapies that selectively degrade disease-causing proteins in tumours while minimising impact on healthy tissues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 4, Building 16, Hexiang Science and Technology Center
  • Qiantang District
  • Hangzhou, Zhejiang 310020
  • China
+86 0571
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Floor 4, Building 16, Hexiang Science and Technology Center
  • Qiantang District
  • Hangzhou, Zhejiang 310020
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ranok Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B1) 09-Jan-2023 $5M Completed Generating Revenue
5. Secondary Transaction - Private 02-Apr-2022 Completed Generating Revenue
4. Early Stage VC (Series B) 15-Jul-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Nov-2020 Completed Generating Revenue
2. Secondary Transaction - Private 23-Dec-2019 $2M Completed Generating Revenue
1. Seed Round 01-Apr-2019 $2M $2M Completed Startup
To view Ranok Therapeutics’s complete valuation and funding history, request access »

Ranok Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ranok Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hyfinity Investments Growth/Expansion Minority
Platanus Family Office Minority
Ling Cheng Ventures Growth/Expansion Minority
Med-Fine Capital Venture Capital Minority
TF Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ranok Therapeutics FAQs

  • When was Ranok Therapeutics founded?

    Ranok Therapeutics was founded in 2018.

  • Where is Ranok Therapeutics headquartered?

    Ranok Therapeutics is headquartered in Hangzhou, China.

  • What is the size of Ranok Therapeutics?

    Ranok Therapeutics has 30 total employees.

  • What industry is Ranok Therapeutics in?

    Ranok Therapeutics’s primary industry is Drug Discovery.

  • Is Ranok Therapeutics a private or public company?

    Ranok Therapeutics is a Private company.

  • What is Ranok Therapeutics’s current revenue?

    The current revenue for Ranok Therapeutics is .

  • How much funding has Ranok Therapeutics raised over time?

    Ranok Therapeutics has raised $55M.

  • Who are Ranok Therapeutics’s investors?

    Hyfinity Investments, Platanus, Ling Cheng Ventures, Med-Fine Capital, and TF Capital are 5 of 6 investors who have invested in Ranok Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process